Compartir
Viral Vectors in Cancer Immunotherapy (Volume 379) (International Review of Cell and Molecular Biology, Volume 379) (en Inglés)
Aranda Vega Fernando,Berraondo Pedro,Galluzzi Lorenzo (Autor)
·
Academic Press
· Nuevo
Viral Vectors in Cancer Immunotherapy (Volume 379) (International Review of Cell and Molecular Biology, Volume 379) (en Inglés) - Aranda Vega Fernando,Berraondo Pedro,Galluzzi Lorenzo
S/ 677,53
S/ 1.355,05
Ahorras: S/ 677,53
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 17 de Julio y el
Jueves 01 de Agosto.
Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.
Reseña del libro "Viral Vectors in Cancer Immunotherapy (Volume 379) (International Review of Cell and Molecular Biology, Volume 379) (en Inglés)"
Viral Vectors in Cancer Immunotherapy, Volume 379 in the International Review of Cell and Molecular Biology presents the latest on cancer immunotherapy and how it has transformed cancer treatment through advances in immune checkpoint inhibitors and adoptive cell therapy. Chapters in this new release include Past, present and future of viral vectors in cancer immunotherapy, Alphaviruses in cancer immunotherapy, Adenoviral-based cancer gene therapy, Armored modified vaccinia Ankara in cancer immunotherapy, Strategies of Semliki Forest virus in immuno-oncology, Maraba virus in cancer immunotherapy, Oncolytic viruses in hematological malignancies, Oncolytic virus for cancer therapies: Overview and future directions, and more. The use of genetically modified viruses allows the expression of pro-inflammatory molecules, while the immune system receives danger signals from the viruses themselves. In some cases, the virus can also induce tumor cell death. This book will review advances in virus-based cancer immunotherapy in both solid tumors and hematologic malignancies.
